ASH Earnings

ASH reported its FY2026Q1 earnings on 2026-02-02, showcasing a revenue of 0.00 against an estimate of 408.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.23 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ASH's FY2026Q1 earnings announcement on 2026-02-02, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, ASH's stock price tends to shift by an average of -0.55% in the 10 days leading up to earnings and +0.89% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ASH’s annual revenue to reach 401.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.02% and EPS estimates Revise Upward by 1.11% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ASH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.02%, while EPS estimates moved Revise Upward by 1.11% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ASH's stock price typically moves by -0.55% in the 10 days before its earnings and +0.89% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.00 and revenue of 401.00M.

The earnings call summary indicates stable financial performance with a strong guidance for FY 2025, cost savings, and growth in innovation-driven initiatives. Market strategy shows potential with investments in microbial protection and biofunctional actives. The Q&A section reveals optimistic outlooks in various sectors, despite some uncertainties in pricing and competitive pressures. The company's strategic plan and capital allocation priorities suggest a focus on growth and shareholder returns, which are likely to be positively received by the market. Given the market cap, a positive stock price movement of 2% to 8% is expected.